AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/113
A PHASE-II STUDY OF INDUCTION CHEMOTHERAPY FOLLOWED BY CONCOMITANT CHEMORADIOTHERAPY FOR NASOPHARYNGEAL CANCER
Authors: GORDON GS BROCKSTEIN BE HARAF DJ KIES MS STENSON K SULZEN L WEICHSELBAUM RR VOKES EE
Citation: Gs. Gordon et al., A PHASE-II STUDY OF INDUCTION CHEMOTHERAPY FOLLOWED BY CONCOMITANT CHEMORADIOTHERAPY FOR NASOPHARYNGEAL CANCER, Journal of investigative medicine, 46(7), 1998, pp. 255-255
MULTIMODALITY THERAPY FOR ESOPHAGEAL CANCER - AN EMERGING ROLE
Authors: VOKES EE MAUER AM
Citation: Ee. Vokes et Am. Mauer, MULTIMODALITY THERAPY FOR ESOPHAGEAL CANCER - AN EMERGING ROLE, The cancer journal from Scientific American, 4(4), 1998, pp. 226-229
A PHASE-II STUDY OF RECOMBINANT HUMAN INTERLEUKIN-4 FOR ADVANCED OR RECURRENT NONSMALL CELL LUNG-CANCER
Authors: VOKES EE FIGLIN R HOCHSTER H LOTZE M RYBAK ME
Citation: Ee. Vokes et al., A PHASE-II STUDY OF RECOMBINANT HUMAN INTERLEUKIN-4 FOR ADVANCED OR RECURRENT NONSMALL CELL LUNG-CANCER, The cancer journal from Scientific American, 4(1), 1998, pp. 46-51
PHASE-II AND PHARMACODYNAMIC STUDIES OF PYRAZINE DIAZOHYDROXIDE (NSC-361456) IN PATIENTS WITH ADVANCED RENAL AND COLORECTAL-CANCER
Authors: VOGELZANG NJ MANI S SCHILSKY RL ANSARI RH TABER D RHINEHART SN GARCIA JC MEYER SC MICK R BROCKSTEIN BE STADLER WM RATAIN MJ VOKES EE
Citation: Nj. Vogelzang et al., PHASE-II AND PHARMACODYNAMIC STUDIES OF PYRAZINE DIAZOHYDROXIDE (NSC-361456) IN PATIENTS WITH ADVANCED RENAL AND COLORECTAL-CANCER, Clinical cancer research, 4(4), 1998, pp. 929-934
PHASE-II AND PHARMACODYNAMIC STUDIES OF PYRAZINE DIAZOHYDROXIDE (NSC-361456) IN PATIENTS WITH ADVANCED RENAL AND COLORECTAL-CANCER
Authors: VOGELZANG NJ MANI S SCHILSKY RL ANSARI RH TABER D RHINEHART SN GARCIA JC MEYER SC MICK R BROCKSTEIN BE STADLER WM RATAIN MJ VOKES EE
Citation: Nj. Vogelzang et al., PHASE-II AND PHARMACODYNAMIC STUDIES OF PYRAZINE DIAZOHYDROXIDE (NSC-361456) IN PATIENTS WITH ADVANCED RENAL AND COLORECTAL-CANCER, Clinical cancer research, 4(4), 1998, pp. 929-934
OSTEORADIONECROSIS OF THE JAWS AS A RISK FACTOR IN RADIOTHERAPY - A REPORT OF AN 8-YEAR RETROSPECTIVE REVIEW
Authors: TOLJANIC JA ALI M HARAF DJ VOKES EE MORAN WJ GRAHAM L
Citation: Ja. Toljanic et al., OSTEORADIONECROSIS OF THE JAWS AS A RISK FACTOR IN RADIOTHERAPY - A REPORT OF AN 8-YEAR RETROSPECTIVE REVIEW, Oncology Reports, 5(2), 1998, pp. 345-349
PHASE-II TRIAL OF URACIL TEGAFUR (UFT) PLUS LEUCOVORIN IN PATIENTS WITH ADVANCED PANCREATIC-CARCINOMA - A UNIVERSITY-OF-CHICAGO PHASE-II CONSORTIUM STUDY/
Authors: MANI S KUGLER JW SCIORTINO DF GARCIA JC ANSARI RH HUMERICKHOUSE R MICHELASSI F POSNER MC SHULMAN KL SCHILSKY RL LIST M VOKES EE BENNER S
Citation: S. Mani et al., PHASE-II TRIAL OF URACIL TEGAFUR (UFT) PLUS LEUCOVORIN IN PATIENTS WITH ADVANCED PANCREATIC-CARCINOMA - A UNIVERSITY-OF-CHICAGO PHASE-II CONSORTIUM STUDY/, Annals of oncology, 9(9), 1998, pp. 1035-1037
INDUCTION CHEMOTHERAPY, SURGERY, AND CONCOMITANT CHEMORADIOTHERAPY FOR CARCINOMA OF THE ESOPHAGUS - A LONG-TERM ANALYSIS
Authors: HOFFMAN PC HARAF DJ FERGUSON MK DRINKARD LC VOKES EE
Citation: Pc. Hoffman et al., INDUCTION CHEMOTHERAPY, SURGERY, AND CONCOMITANT CHEMORADIOTHERAPY FOR CARCINOMA OF THE ESOPHAGUS - A LONG-TERM ANALYSIS, Annals of oncology, 9(6), 1998, pp. 647-651
A PHASE I-II STUDY OF PACLITAXEL, IFOSFAMIDE, AND VINORELBINE WITH FILGRASTIM (RHG-CSF) SUPPORT IN ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: MASTERS GA MAUER AM HOFFMAN PC WYKA D SAMUELS BL KRAUSS SA WATSON S GOLOMB H VOKES EE
Citation: Ga. Masters et al., A PHASE I-II STUDY OF PACLITAXEL, IFOSFAMIDE, AND VINORELBINE WITH FILGRASTIM (RHG-CSF) SUPPORT IN ADVANCED NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 9(6), 1998, pp. 677-680
ENHANCING THE THERAPEUTIC INDEX OF CONCOMITANT CHEMORADIOTHERAPY FOR HEAD AND NECK-CANCER
Authors: VOKES EE PAJAK TF
Citation: Ee. Vokes et Tf. Pajak, ENHANCING THE THERAPEUTIC INDEX OF CONCOMITANT CHEMORADIOTHERAPY FOR HEAD AND NECK-CANCER, Annals of oncology, 9(5), 1998, pp. 471-473
A PHASE-II STUDY OF 9-AMINOCAMPTOTHECIN IN ADVANCED NONSMALL CELL LUNG-CANCER
Authors: VOKES EE ANSARI RH MASTERS GA HOFFMAN PC KLEPSCH A RATAIN MJ SCIORTINO DF LAD TE KRAUSS S FISHKIN PAS GOLOMB HM
Citation: Ee. Vokes et al., A PHASE-II STUDY OF 9-AMINOCAMPTOTHECIN IN ADVANCED NONSMALL CELL LUNG-CANCER, Annals of oncology, 9, 1998, pp. 253-253
A PHASE-II TRIAL OF CI-980 IN ADVANCED NONSMALL CELL LUNG-CANCER
Authors: VOKES EE ARRIETA R LAD T MASTERS GA HOFFMAN PC ANSARI R SCHUMM P GOLOMB HM
Citation: Ee. Vokes et al., A PHASE-II TRIAL OF CI-980 IN ADVANCED NONSMALL CELL LUNG-CANCER, Annals of oncology, 9, 1998, pp. 380-380
A PHASE-1 STUDY OF RALTITREXED (TOMUDEX(R)) AND PACLITAXEL
Authors: VOKES EE BERTUCCI D VOGELZANG NJ MANI S LOWERY C RATAIN MJ
Citation: Ee. Vokes et al., A PHASE-1 STUDY OF RALTITREXED (TOMUDEX(R)) AND PACLITAXEL, Annals of oncology, 9, 1998, pp. 462-462
PHASE-I STUDY OF THE DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) INHIBITOR ENILURACIL (GW776C85) AND ORAL 5-FU WITH CONCOMITANT RADIOTHERAPY (XRT) FOR RECURRENT OR ADVANCED HEAD AND NECK-CANCER (HNC)
Authors: VOKES EE HUMERICKHOUSE R DOLAN E BROCKSTEIN B HARAF D STENSON K KIES M SULZEN L HOUSE L RATAIN MJ
Citation: Ee. Vokes et al., PHASE-I STUDY OF THE DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) INHIBITOR ENILURACIL (GW776C85) AND ORAL 5-FU WITH CONCOMITANT RADIOTHERAPY (XRT) FOR RECURRENT OR ADVANCED HEAD AND NECK-CANCER (HNC), Annals of oncology, 9, 1998, pp. 597-597
A PHASE-II STUDY OF 9-AMINOCAMPTOTHECIN IN ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: VOKES EE ANSARI RH MASTERS GA HOFFMAN PC KLEPSCH A RATAIN MJ SCIORTINO DF LAD TE KRAUSS S FISHKIN PAS GOLOMB HM
Citation: Ee. Vokes et al., A PHASE-II STUDY OF 9-AMINOCAMPTOTHECIN IN ADVANCED NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 9(10), 1998, pp. 1085-1090
INDUCTION CHEMOTHERAPY, SURGERY, AND CONCOMITANT CHEMORADIOTHERAPY FOR CARCINOMA OF THE ESOPHAGUS - A LONG-TERM ANALYSIS. (VOL 9, PG 647, 1998)
Authors: HOFFMAN PC HARAF DJ FERGUSON MK DRINKARD LC VOKES EE
Citation: Pc. Hoffman et al., INDUCTION CHEMOTHERAPY, SURGERY, AND CONCOMITANT CHEMORADIOTHERAPY FOR CARCINOMA OF THE ESOPHAGUS - A LONG-TERM ANALYSIS. (VOL 9, PG 647, 1998), Annals of oncology, 9(10), 1998, pp. 1143-1143
ORAL 5-FU ALTERNATIVES FOR THE TREATMENT OF HEAD AND NECK-CANCER
Authors: VOKES EE BROCKSTEIN BE HUMERICKHOUSE R HARAF DJ
Citation: Ee. Vokes et al., ORAL 5-FU ALTERNATIVES FOR THE TREATMENT OF HEAD AND NECK-CANCER, Oncology, 12(10), 1998, pp. 35-38
CLINICAL-STUDIES IN NONSMALL CELL LUNG-CANCER - THE CALGB EXPERIENCE
Authors: VOKES EE GREEN MR
Citation: Ee. Vokes et Mr. Green, CLINICAL-STUDIES IN NONSMALL CELL LUNG-CANCER - THE CALGB EXPERIENCE, Cancer investigation, 16(2), 1998, pp. 72-79
INDUCTION CHEMOTHERAPY FOLLOWED BY CONCURRENT CHEMORADIATION FOR ADVANCED HEAD AND NECK-CANCER - IMPROVED DISEASE-CONTROL AND SURVIVAL
Authors: KIES MS HARAF DJ ATHANASIADIS I KOZLOFF M MITTAL B PELZER H RADEMAKER AW WENIG B WEICHSELBAUM RR VOKES EE
Citation: Ms. Kies et al., INDUCTION CHEMOTHERAPY FOLLOWED BY CONCURRENT CHEMORADIATION FOR ADVANCED HEAD AND NECK-CANCER - IMPROVED DISEASE-CONTROL AND SURVIVAL, Journal of clinical oncology, 16(8), 1998, pp. 2715-2721
PHASE-II TRIAL OF PACLITAXEL AND TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT IN STAGE-IV BREAST-CANCER
Authors: FLEMING GF KUGLER JW HOFFMAN PC ANSARI R BITRAN JD KLEPSCH A MALONE D FASANMADE AA RATAIN MJ VOKES EE
Citation: Gf. Fleming et al., PHASE-II TRIAL OF PACLITAXEL AND TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT IN STAGE-IV BREAST-CANCER, Journal of clinical oncology, 16(6), 1998, pp. 2032-2037
PHASE-I STUDY OF VINORELBINE, CISPLATIN, AND CONCOMITANT THORACIC RADIATION IN THE TREATMENT OF ADVANCED CHEST MALIGNANCIES
Authors: MASTERS GA HARAF DJ HOFFMAN PC DRINKARD LC KRAUSS SA FERGUSON MK OLAK J SAMUELS BL GOLOMB HM VOKES EE
Citation: Ga. Masters et al., PHASE-I STUDY OF VINORELBINE, CISPLATIN, AND CONCOMITANT THORACIC RADIATION IN THE TREATMENT OF ADVANCED CHEST MALIGNANCIES, Journal of clinical oncology, 16(6), 1998, pp. 2157-2163
PHASE-I STUDY OF CONCOMITANT CHEMORADIOTHERAPY WITH PACLITAXEL, FLUOROURACIL, AND HYDROXYUREA WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT FOR PATIENTS WITH POOR-PROGNOSIS CANCER OF THE HEAD AND NECK
Authors: BROCKSTEIN B HARAF DJ STENSON K FASANMADE A STUPP R GLISSON B LIPPMAN SM RATAIN MJ SULZEN L KLEPSCH A WEICHSELBAUM RR VOKES EE
Citation: B. Brockstein et al., PHASE-I STUDY OF CONCOMITANT CHEMORADIOTHERAPY WITH PACLITAXEL, FLUOROURACIL, AND HYDROXYUREA WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT FOR PATIENTS WITH POOR-PROGNOSIS CANCER OF THE HEAD AND NECK, Journal of clinical oncology, 16(2), 1998, pp. 735-744
PHASE-I STUDY OF DOCETAXEL WITH CONCOMITANT THORACIC RADIATION-THERAPY
Authors: MAUER AM MASTERS GA HARAF DJ HOFFMAN PC WATSON SM GOLOMB HM VOKES EE
Citation: Am. Mauer et al., PHASE-I STUDY OF DOCETAXEL WITH CONCOMITANT THORACIC RADIATION-THERAPY, Journal of clinical oncology, 16(1), 1998, pp. 159-164
AN UPDATE ON NORTH-AMERICAN RANDOMIZED STUDIES IN NONSMALL CELL LUNG-CANCER
Authors: BUNN PA VOKES EE LANGER CJ SCHILLER JH
Citation: Pa. Bunn et al., AN UPDATE ON NORTH-AMERICAN RANDOMIZED STUDIES IN NONSMALL CELL LUNG-CANCER, Seminars in oncology, 25(4), 1998, pp. 2-10
GEMCITABINE AND RADIATION-THERAPY FOR NONSMALL CELL LUNG-CANCER
Authors: VOKES EE GREGOR A TURRISI AT
Citation: Ee. Vokes et al., GEMCITABINE AND RADIATION-THERAPY FOR NONSMALL CELL LUNG-CANCER, Seminars in oncology, 25(4), 1998, pp. 66-69
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>